This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.
Lieferbar
ISBN | 9781461416616 |
---|---|
Sprache | eng |
Cover | Clinical Trials,Pharma,Statistical Concepts,Statistics, C, Biomedicine, general, Pharmaceutical Sciences/Technology, Biomedical Research, Pharmaceutics, Biomedical and Life Sciences, Medicine, Pharmaceutical technology, Industrial chemistry & chemical engineering, Kartonierter Einband (Kt) |
Verlag | Springer Nature EN |
Jahr | 2011 |
Dieser Artikel hat noch keine Bewertungen.